NAFDAC: Dove soap recalled due to harmful chemical lilyral
According to a notification from the National Agency for Food and Drug Administration and Control (NAFDAC), Dove Beauty Cream soap (100g) (batch number 81832M 08), manufactured in Germany, is being recalled due to the presence of harmful chemicals in its ingredients.
NAFDAC stated on its website that the soap contains 2-(4-tert-butylbenzyl)propionaldehyde (BMHCA). This chemical is banned in cosmetics due to its high potential for health hazards. It is commonly found in perfumes and is known to cause skin sensitization and reproductive damage.
“The presence of 2-(4-tert-butylbenzyl)propionaldehyde in the product is a violation of the Cosmetics Regulations and poses serious health concerns. 2-(4-tert-butylbenzyl)propionaldehyde is banned for use in cosmetics as it may cause reproductive damage and skin sensitization and has been banned in several countries, including across the European Union,” the agency said.
NAFDAC stressed that the importation of the soap into Nigeria is prohibited. The agency also found that this batch of Dove soap and other Dove products such as Derma Spa Goodness and Men Care have been recalled or banned in several countries for the same reason.
The agency urged consumers who have purchased the soap to stop using it immediately and return the remaining stock to NAFDAC offices, and healthcare professionals and consumers to report any adverse reactions experienced while using the product through NAFDAC’s electronic reporting platform or mobile app.
2026-07-26
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Dove enters natural deodorant category with VITAMINCARE+
-
FDA approves bemotrizinol, a long-used UV filter, for U.S. sunscreens
-
China Releases 15th Five-Year Carbon-Peaking Action Plan, Pushing Coal Chemicals into a Mandatory Low-Carbon Upgrade Cycle
-
U.S. Exempts Critical Chemical Manufacturers from Emissions Rules for Two Years
-
关于将二氟乙咪酯等16种物质列入《非药用类麻醉药品和精神药品目录》的公告 Announcement on the Inclusion of 16 Substances including Difluoroetomidate in the Catalogue of Non-Medicinal Narcotic Drugs and Psychotropic Substances
-
Four Fine Chemical Units of Huajin Aramco Project – HDPE, EO/EG, etc. – Reach Mechanical Completion
-
Vera’s New Kidney Drug Wins FDA Approval, Carrying a $425,000 Annual Price
-
South Korea Expands Mandatory GMO Labeling to Highly Processed Foods
-
Bayer and Syngenta Score Consecutive Regulatory and Legal Wins in the U.S.
-
Thymol Gel Wins EPA Approval for Beekeepers
Recommend Reading
-
FSANZ Moves Toward Approval of Insect-Resistant Corn COR121
-
FDA Tightens the Solvent Side of Natural Color Production
-
India’s Tariff Cuts Could Lower Agrochemical Costs
-
FDA Slows Two Natural Color Approvals, but the Additive Shift Is Still Moving
-
EPA Clears Backlog of Refinery Biofuel Waivers, Sparking Fears for Ethanol Demand
-
On March 6, the isopropyl alcohol market in China saw a significant increase in prices
-
Premium Global Chemical Sourcing Requests (8-10Jun, 2026)
-
Methanol market prices continue to rise in China
-
BDO Market Conditions Show Signs of Recovery
-
EDTA (Ethylenediaminetetraacetic acid): Chelation Therapy & Industrial Uses